- Home
- PKE vs AQST Comparison
PKE vs AQST Comparison
Compare PKE & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKE
- AQST
- Stock Information
- Founded
- PKE 1954
- AQST 2004
- Country
- PKE United States
- AQST United States
- Employees
- PKE N/A
- AQST N/A
- Industry
- PKE Military/Government/Technical
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- PKE Industrials
- AQST Health Care
- Exchange
- PKE Nasdaq
- AQST Nasdaq
- Market Cap
- PKE 352.8M
- AQST 390.4M
- IPO Year
- PKE N/A
- AQST 2018
- Fundamental
- Price
- PKE $19.09
- AQST $3.98
- Analyst Decision
- PKE
- AQST Strong Buy
- Analyst Count
- PKE 0
- AQST 6
- Target Price
- PKE N/A
- AQST $10.67
- AVG Volume (30 Days)
- PKE 141.3K
- AQST 1.3M
- Earning Date
- PKE 10-14-2025
- AQST 08-11-2025
- Dividend Yield
- PKE 2.63%
- AQST N/A
- EPS Growth
- PKE 4.18
- AQST N/A
- EPS
- PKE 0.34
- AQST N/A
- Revenue
- PKE $63,456,000.00
- AQST $44,132,000.00
- Revenue This Year
- PKE N/A
- AQST N/A
- Revenue Next Year
- PKE N/A
- AQST $51.62
- P/E Ratio
- PKE $53.98
- AQST N/A
- Revenue Growth
- PKE 16.60
- AQST N/A
- 52 Week Low
- PKE $11.97
- AQST $2.12
- 52 Week High
- PKE $20.73
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- PKE 65.23
- AQST 52.27
- Support Level
- PKE $17.25
- AQST $3.81
- Resistance Level
- PKE $18.86
- AQST $4.26
- Average True Range (ATR)
- PKE 0.62
- AQST 0.24
- MACD
- PKE -0.03
- AQST -0.02
- Stochastic Oscillator
- PKE 92.18
- AQST 50.00
About PKE Park Aerospace Corp.
Park Aerospace Corp designs is an aerospace company which develops and manufactures solution and hot-melt composite materials used to produce composite structures for the aerospace markets. Its composite materials include film adhesives and lightning strike protection materials. Its composite materials are used to produce primary and secondary structures for jet engines, large and regional transport aircraft, military aircraft, Unmanned Aerial Vehicles (UAVs commonly referred to as drones), business jets, general aviation aircraft and rotary wing aircraft. The Company's products are sold to customers in North America, Asia and Europe.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.